Boston Scientific Corporation
BSX
Peringkat dalam Saham
#409
Deskripsi perusahaan ini hanya tersedia dalam bahasa Inggris.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Harga Saham
$41.88
Terakhir disinkronkan: 2026-10-30
Kapitalisasi Pasar
$60.69B
Perubahan (1 hari)
-1.89%
Perubahan (1 tahun)
-58.42%
Negara
US
Data saham: Financial Modeling PrepΒ·Diperbarui Β·Bukan saran investasiΒ·Cara kami menghitung
Perdagangan Boston Scientific Corporation (BSX)
Kategori
Healthcare
EPS untuk Boston Scientific Corporation (BSX)
EPS per September 2026 TTM: $2.37
Menurut laporan keuangan terbaru dan harga saham Boston Scientific Corporation, EPS perusahaan saat ini (TTM) adalah $2.37. Pada akhir 2025, perusahaan memiliki EPS sebesar $1.96 peningkatan dibandingkan EPS tahun 2024 sebesar $1.26.
Riwayat EPS untuk Boston Scientific Corporation dari 2000 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Perubahan |
|---|---|---|
| 2026 (TTM) | $2.37 | 20.92% |
| 2025 | $1.96 | 55.56% |
| 2024 | $1.26 | 16.61% |
| 2023 | $1.08 | 140.75% |
| 2022 | $0.45 | -35.19% |
| 2021 | $0.69 | -952.83% |
| 2020 | $-0.08 | -102.40% |
| 2019 | $3.38 | 179.14% |
| 2018 | $1.21 | 1,412.50% |
| 2017 | $0.08 | -69.23% |
| 2016 | $0.26 | -244.44% |
| 2015 | $-0.18 | 100.00% |
| 2014 | $-0.09 | 0.00% |
| 2013 | $-0.09 | -96.89% |
| 2012 | $-2.89 | -1,096.55% |
| 2011 | $0.29 | -141.43% |
| 2010 | $-0.70 | 2.94% |
| 2009 | $-0.68 | -50.00% |
| 2008 | $-1.36 | 312.12% |
| 2007 | $-0.33 | -88.26% |
| 2006 | $-2.81 | -469.74% |
| 2005 | $0.76 | -40.16% |
| 2004 | $1.27 | 122.81% |
| 2003 | $0.57 | 23.91% |
| 2002 | $0.46 | -807.69% |
| 2001 | $-0.07 | -114.13% |
| 2000 | $0.46 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| $2.70 | 13.92% |
US
|
|
| $4.09 | 72.57% |
IE
|
|
| $9.45 | 298.73% |
US
|
|
| $2.21 | -6.84% |
DE
|
|
| $1.74 | -26.58% |
US
|
Pertanyaan tentang laba per saham (EPS) Boston Scientific Corporation
Berapa laba per saham (EPS) Boston Scientific Corporation?
Per Sep 2026, laba per saham (EPS) Boston Scientific Corporation dalam 12 bulan terakhir sebesar $2.37.
Berapa laba per saham (EPS) Boston Scientific Corporation pada tahun 2025?
Pada tahun 2025, laba per saham (EPS) Boston Scientific Corporation sebesar $1.96, naik 55.56% dibanding tahun 2024 ($1.26).
Bagaimana perubahan laba per saham (EPS) Boston Scientific Corporation sejak tahun 2020?
Dari tahun 2020 hingga 2025, laba per saham (EPS) Boston Scientific Corporation tertinggi pada tahun 2025 ($1.96) dan terendah pada tahun 2020 ($-0.08).
Bagaimana laba per saham (EPS) Boston Scientific Corporation dibandingkan dengan perusahaan sejenis?
Dengan $2.37, laba per saham (EPS) Boston Scientific Corporation lebih tinggi daripada 2 dari 5 perusahaan sejenis yang tercantum di atas. Yang tertinggi di antara perusahaan tersebut adalah Stryker Corporation, dengan $9.45.